Home > Products > CD64 & GD2 > Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Triple Body)

Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Triple Body)  (TRIB-H300)

Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD64 antibody are both extended with the scFv fragment from an anti-GD2 antibody. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.

Specifications

Targets
CD64 & GD2
Type
Triple Body
Species Reactivity
Human
Target 1
CD64
Host Animal 1
Human
Target 2
GD2
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Neuroblastoma; Osteosarcoma; MelanomaSolid tumors

Targets

Target 1
CD64
Gene ID
UniProt ID
Alternative Names
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Target 2
GD2
Alternative Names
Ganglioside GD2; GD2; Ganglioside; Disialoganglioside GD2

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Triple Body) (TRIB-H300). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD64 & GD2"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: